CBIO

Crescent Biopharma, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, focused on developing cutting-edge protease therapeutics aimed at hemostasis and complement regulation. With a robust pipeline of innovative candidates targeting serious blood coagulation and immune response disorders, the company is strategically positioned to address unmet medical needs. By harnessing advanced research methodologies and proprietary technologies, Crescent Biopharma is set to deliver transformative solutions, establishing itself as a significant contributor in the rapidly evolving biopharmaceutical landscape.